Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Sep 7:148:e202.
doi: 10.1017/S0950268820002022.

D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis

Affiliations
Meta-Analysis

D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis

Daniel Martin Simadibrata et al. Epidemiol Infect. .

Abstract

D-dimer level on admission is a promising biomarker to predict mortality in patients with COVID-19. In this study, we reviewed the association between on-admission D-dimer levels and all-cause mortality risk in COVID-19 patients. Peer-reviewed studies and preprints reporting categorised D-dimer levels on admission and all-cause mortality until 24 May 2020 were searched for using the following keywords: 'COVID-19', 'D-dimer' and 'Mortality'. A meta-analysis was performed to determine the pooled risk ratio (RR) for all-cause mortality. In total, 2911 COVID-19 patients from nine studies were included in this meta-analysis. Regardless of the different D-dimer cut-off values used, the pooled RR for all-cause mortality in patients with elevated vs. normal on-admission D-dimer level was 4.77 (95% confidence interval (CI) 3.02-7.54). Sensitivity analysis did not significantly affect the overall mortality risk. Analysis restricted to studies with 0.5 μg/ml as the cut-off value resulted in a pooled RR for mortality of 4.60 (95% CI 2.72-7.79). Subgroup analysis showed that the pooled all-cause mortality risk was higher in Chinese vs. non-Chinese studies (RR 5.87; 95% CI 2.67-12.89 and RR 3.35; 95% CI 1.66-6.73; P = 0.29). On-admission D-dimer levels showed a promising prognostic role in predicting all-cause mortality in COVID-19 patients, elevated D-dimer levels were associated with increased risk of mortality.

Keywords: COVID-19; Coronavirus disease; D-dimer; mortality; prognosis.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
PRISMA diagram showing the study selection for inclusion in the meta-analysis. Literature search identifying peer-reviewed papers, preprints and grey literature was done from database conception to 24 May 2020.
Fig. 2.
Fig. 2.
All-cause mortality risk. Forest plot using the Mantel–Haenszel random-effect model demonstrating the association between D-dimer levels on admission and all-cause mortality risk for all included studies.
Fig. 3.
Fig. 3.
All-cause mortality risk for studies with D-dimer cut-off value of 0.5 μg/ml. Forest plot using the Mantel–Haenszel fixed-effect model showing the association between D-dimer levels on admission and all-cause mortality risk for studies with D-dimer cut-off value of 0.5 μg/ml.
Fig. 4.
Fig. 4.
Subgroup analysis by study location. Forest plot using the Mantel–Haenszel random-effect model comparing the association between D-dimer levels on admission and all-cause mortality risk in Chinese and non-Chinese studies. Non-Chinese studies included studies done in the USA and Italy.

References

    1. Sohrabi C et al. (2020) World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery 76, 71–76. - PMC - PubMed
    1. Jose RJ and Manuel A (2020) COVID-19 cytokine storm: the interplay between inflammation and coagulation. The Lancet Respiratory Medicine 8, e46–e47. - PMC - PubMed
    1. Ye Q, Wang B and Mao J (2020) The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. Journal of Infection 80, 607–613. - PMC - PubMed
    1. Mehta P et al. (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet 395, 1033–1034. - PMC - PubMed
    1. Emanuel EJ et al. (2020) Fair allocation of scarce medical resources in the time of Covid-19. The New England Journal of Medicine 382, 2049–2055. - PubMed